Passionate about making a profound impact on peoples’ lives
Assembly Bio is an ambitious biopharmaceutical company with cutting-edge therapeutic candidates capable of improving the lives of millions living with devastating viral and liver diseases. We have multiple ongoing clinical programs focused on the development of novel treatments for herpesviruses, hepatitis delta virus (HDV), cholestatic liver diseases and hepatitis B virus (HBV). Further, our research organization is dedicated to the discovery of new therapies to change the treatment paradigm for individuals living with serious viral and liver diseases.
Advancing life-changing therapies for patients with serious viral and liver diseases
Assembly Bio’s team is focused on advancing treatment options for people through the discovery and development of novel treatments for serious viral and liver diseases. We are leveraging our extensive expertise in virology and liver disease to deliver breakthrough therapeutics with the potential to improve outcomes for individuals struggling with the impacts of serious viral and liver diseases.
Management Team
Chief Executive Officer & President, Director
Chief Scientific Officer
Chief Medical Officer
Senior Vice President, Preclinical Research and Development
Chief Human Resources Officer
Chief Manufacturing Officer
Board of Directors
Chairman of the Board, Non-Executive
Director
Director
Director
Director
Director
Director
Director
Chief Executive Officer & President, Director
Contact Us
FOR GENERAL INFORMATION,
PLEASE CONTACT:
833.509.4583
info@assemblybio.com
FOR QUESTIONS ABOUT COLLABORATION
OPPORTUNITIES, PLEASE CONTACT:
BD@assemblybio.com